Immatics (IMTX) Net Margin (2019 - 2026)
Immatics (IMTX) posted Net Margin of 179.29% for Q4 2025, up 81.69% sequentially from 979.35% in Q3 2025, and down 25905.0% YoY from N/an in Q4 2024.
Analysis
Immatics (IMTX) Net Margin (2019 - 2026) Analysis & Trends
Immatics has reported Net Margin for 7 years, with the latest figure at 179.29% in Q4 2025.
- Quarterly Net Margin fell 25905.0% year-over-year to 179.29% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 415.52% (down 42437.0% YoY) and the FY2025 annual result came in at 407.01%, down 41677.0% from the prior year.
- Net Margin grew to 179.29% in Q4 2025 per IMTX's latest filing, from 979.35% in the prior quarter.
- Over five years, Net Margin peaked at 83.24% in Q1 2022 and troughed at 1485.07% in Q2 2025.
- A 5-year average of 254.49% and a median of 120.85% in 2022 frame the typical range for Net Margin.
- The sharpest annual moves came in 2021 and 2025: Net Margin jumped 166083 bps in 2021, then tumbled 138914 bps in 2025.
- Over 5 years, Net Margin stood at 106.74% in 2021, then surged by 106 bps to 5.89% in 2022, then tumbled by 2889 bps to 164.24% in 2023, then surged by 149 bps to 79.75% in 2024, then slumped by 325 bps to 179.29% in 2025.
- According to Business Quant data, Net Margin over the past three periods registered 179.29%, 979.35%, and 1485.07% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -539.31% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 13.90% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 12.74% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 12.09% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -3.12% |
| 10 | Immatics | 1.17 Bn | 711.21 Mn | - | -683.42% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -683.42% |
| Mar 31, 2026 | -759.51% |
| Dec 31, 2025 | -179.29% |
| Sep 30, 2025 | -979.35% |
| Jun 30, 2025 | -1,485.07% |
| Mar 31, 2025 | -214.48% |
| Dec 31, 2024 | 79.75% |
| Sep 30, 2024 | -16.95% |
| Jun 30, 2024 | -95.93% |
| Mar 31, 2024 | -10.09% |
| Dec 31, 2023 | -278.61% |
| Sep 30, 2023 | -447.00% |
| Jun 30, 2023 | -110.09% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 5.89% |
| Sep 30, 2022 | -131.60% |
| Jun 30, 2022 | -67.91% |
| Mar 31, 2022 | 83.24% |
| Dec 31, 2021 | 1,080.20% |
| Sep 30, 2021 | -422.21% |